/CGNSF
CGNSF Stock - Cognetivity Neurosciences Ltd.
Healthcare|Medical - Healthcare Information ServicesOTC
$0.00+0.00%
+$0.00 (+0.00%) • Dec 19
55
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.20
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.78
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for CGNSF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.06
52W High$0.01
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $45,366 | N/A | N/A | N/A | N/A |
| Gross Profit | $-2,129,868 | $-24,530 | $-11,448 | $-9,292 | $-3,942 |
| Gross Margin | -4694.9% | N/A | N/A | N/A | N/A |
| Operating Income | $-6,290,611 | $-13,036,460 | $-2,393,270 | $-2,604,801 | $-4,212,737 |
| Net Income | $-7,433,815 | $-13,127,327 | $-1,928,097 | $-2,645,114 | $-4,192,618 |
| Net Margin | -16386.3% | N/A | N/A | N/A | N/A |
| EPS | $-0.09 | $-0.18 | $-0.03 | $-0.06 | $-0.10 |
Company Overview
Cognetivity Neurosciences Ltd. operates as a healthcare company. It develops an integrated cognitive assessment, a cognitive testing platform for use in medical, commercial, and consumer environments that helps to detect the earliest signs of impairment by testing the performance of large areas of the brain to support the diagnosis of dementia; and offers OptiMind, a wellness app. The company was formerly known as Utor Capital Corp. and changed its name to Cognetivity Neurosciences Ltd. in December 2017. Cognetivity Neurosciences Ltd. was incorporated in 2015 and is headquartered in Vancouver, Canada.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
CGNSFBeat Rate
0%
Last 8 quarters
Avg Surprise
-148.4%
EPS vs Estimate
Beats / Misses
0/6
2 met exactly
Latest EPS
$-0.02
Q4 2023
EPS Surprise History
Q1 22
No data
Q2 22
-100.0%
$-0.02vs$-0.01
Q3 22
-100.0%
$-0.02vs$-0.01
Q4 22
-125.9%
$-0.02vs$-0.01
Q1 23
No data
Q2 23
-145.1%
$-0.02vs$-0.01
Q3 23
No data
Q4 23
-16.2%
$-0.02vs$-0.01
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2025 | Feb 26, 2025 | — | — | — | — |
Q4 2024 | Dec 27, 2024 | — | — | — | — |
Q3 2024 | Sep 27, 2024 | — | — | — | — |
Q2 2024 | Jun 28, 2024 | — | — | — | — |
Q1 2024 | Jan 2, 2024 | — | — | — | — |
Q4 2023 | Dec 29, 2023 | $-0.01 | $-0.02 | -16.2% | ✗ MISS |
Q3 2023 | Sep 29, 2023 | — | $-0.02 | — | — |
Q2 2023 | Jun 29, 2023 | $-0.01 | $-0.02 | -145.1% | ✗ MISS |
Q1 2023 | Jan 31, 2023 | — | $-0.02 | — | — |
Q4 2022 | Dec 16, 2022 | $-0.01 | $-0.02 | -125.9% | ✗ MISS |
Q3 2022 | Sep 29, 2022 | $-0.01 | $-0.02 | -100.0% | ✗ MISS |
Q2 2022 | Jun 29, 2022 | $-0.01 | $-0.02 | -100.0% | ✗ MISS |
Q1 2022 | Jan 31, 2022 | — | $-0.05 | — | — |
Q4 2021 | Dec 17, 2021 | $-0.01 | $-0.08 | -700.0% | ✗ MISS |
Q3 2021 | Sep 29, 2021 | $-0.01 | $-0.01 | 0.0% | = MET |
Q2 2021 | Jun 29, 2021 | $-0.01 | $-0.01 | 0.0% | = MET |
Q1 2021 | Jan 31, 2021 | — | $-0.01 | — | — |
Q4 2020 | Dec 23, 2020 | — | $-0.00 | — | — |
Q3 2020 | Sep 28, 2020 | — | $-0.01 | — | — |
Q2 2020 | Jun 29, 2020 | — | $-0.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about CGNSF
What is CGNSF's current stock price?
Cognetivity Neurosciences Ltd. (CGNSF) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for CGNSF?
No analyst price targets are currently available for this stock.
What sector is Cognetivity Neurosciences Ltd. in?
Cognetivity Neurosciences Ltd. operates in the Healthcare sector, specifically within the Medical - Healthcare Information Services industry. The company is traded on the OTC exchange.
What is CGNSF's market cap?
Cognetivity Neurosciences Ltd. has a market capitalization of $0.00 billion, making it a small-cap company.
Does CGNSF pay dividends?
No, Cognetivity Neurosciences Ltd. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBLFE
BioLife Sciences Inc.
$0.00
Mkt Cap: $0.0B
BNYN
Banyan Corp.
$0.00
Mkt Cap: $0.0B
CBDL
CBD Life Sciences Inc.
$0.00
Mkt Cap: $0.0B
EMED
Electromedical Technologies, Inc.
$0.00
Mkt Cap: $0.0B
EMYSF
Easy Technologies Inc.
$0.01
Mkt Cap: $0.0B
HPMM
Hemp Naturals, Inc.
$0.00
Mkt Cap: $0.0B
IVIXF
Invion Limited
$0.04
Mkt Cap: $0.0B
RMRK
Rimrock Gold Corp.
$0.00
Mkt Cap: $0.0B
SHWZ
Medicine Man Technologies, Inc.
$0.00
Mkt Cap: $0.0B
VRSYF
VMS Rehab Systems, Inc.
$0.00
Mkt Cap: $0.0B
Explore stocks similar to CGNSF for comparison